Reduced oxidative damage in ALS by high-dose enteral melatonin treatment.
Weishaupt JH, Bartels C, Pölking E, Dietrich J, Rohde G, Poeggeler B, Mertens N, Sperling S, Bohn M, Hüther G, Schneider A, Bach A, Sirén AL, Hardeland R, Bähr M, Nave KA, Ehrenreich H.
Weishaupt JH, et al. Among authors: bartels c.
J Pineal Res. 2006 Nov;41(4):313-23. doi: 10.1111/j.1600-079X.2006.00377.x.
J Pineal Res. 2006.
PMID: 17014688
Clinical Trial.